Wan, XS; Wisskirchen, K; Jin, T; Yang, L; Wang, XR; Wu, XA; Liu, F; Wu, Y; Ma, C; Pang, Y; Li, Q; Zhang, K; Protzer, U; Du, SD (2024) Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting